METDA: Depression and/or Anxiety Study


Study Information
Purpose of Study
Primarily to test the efficacy of MET-2, a gut repopulating biological product, on depression and anxiety symptoms, as well as the safety and tolerability of the product.
Associated Lab
Milev Laboratory
Location
Providence Care Hospital.
Investigators
Arthi Chinna Meyyappan
Benefits of Participating

Compensation
$50 for every in-hospital visit (for a total of 5 visits).

Inclusions:
Between the ages 18-65 Depressed or anxious Not currently taking any antidepressants
Exclusions:
You are currently not taking any antidepressent medication
Participant Expectations


Login or Sign Up to Get Started